Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development

OBJECTIVE: Despite recommendations by professional organizations that all pregnant women receive inactivated influenza vaccine, safety concerns remain a barrier. Our objective was to assess the effect of trivalent influenza vaccines (IIV3) during pregnancy on parent report 6-month infant development...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Avalos, Lyndsay A., Ferber, Jeannette, Zerbo, Ousseny, Naleway, Allison L., Bulkley, Joanna, Thompson, Mark, Cragan, Janet, Williams, Jennifer, Odouli, Roxana, Kauffman, Tia L., Ball, Sarah, Shifflett, Pat, Li, De-Kun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7309563/
https://ncbi.nlm.nih.gov/pubmed/32033850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.01.059
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak